March 01, 2021
Article
Injectables are driving the growth because they can be taken less frequently and adherence is a problem with oral medications.
February 24, 2021
Article
The FDA approved the use of Entresto in a broader group of heart failure patients that includes a large percentage of those with preserved ejection fraction.
February 22, 2021
Article
Application to the FDA is based on results from a placebo-controlled trial showing a 15% decrease in body weight among those who are obese or overweight.